BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease

«Active Biotech

Below is an extended Active Biotech research listing. Click here to return to the Active Biotech main Biocorporate entry.

Recent Publications by Active Biotech:

Increased degradation rate of nitrososureas in media containing carbonate.
The stability of two nitrosoureas, tauromustine and lomustine, has been...
16th October, 2008
Department of Preclinical Development, Active Biotech Research AB, P.O. In Vitro Cell Dev Biol Anim. 2008 Oct 15.
DOI Direct Link
Combining tumor-targeted superantigens with interferon-alpha results in synergistic anti-tumor effects.
In this study we explored the possibility of improving the anti-tumor...
9th April, 2008
Active Biotech Research AB, P.O. Box 724, SE-220 07 Lund, Sweden. Int Immunopharmacol. 2008 Mar;8(3):442-52. Epub 2007 Dec 7.
DOI Direct Link
Discovery of selective small-molecule CD80 inhibitors.
Protein-protein interactions are widely found in biological systems...
19th August, 2007
Active Biotech Research AB, Lund, Sweden. J Biomol Screen. 2007 Jun;12(4):464-72. Epub 2007 Apr 13.
DOI Direct Link
Determination of the immunomodulator laquinimod in human plasma by liquid chromatography/tandem mass spectrometry; development, validation and application of two methods in clinical pharmacokinetic profiling.
Laquinimod (ABR-215062) is a synthetic compound currently undergoing...
20th January, 2007
Research and Development Laboratories, Active Biotech Research AB, Box Rapid Commun Mass Spectrom. 2006;20(22):3313-8.
DOI Direct Link
Synthesis and reactivity of laquinimod, a quinoline-3-carboxamide: intramolecular transfer of the enol proton to a nitrogen atom as a plausible mechanism for ketene formation.
5-Chloro-N-ethyl-1,2-dihydro-4-hydroxy-1-methyl-2-oxo-N-phenyl-3-quinoline...
12th December, 2006
R&D Laboratories, Active Biotech Research AB, Box 724, SE-220 07 Lund, J Org Chem. 2006 Feb 17;71(4):1658-67.
DOI Direct Link
Inhibition of the development of chronic experimental autoimmune encephalomyelitis by laquinimod (ABR-215062) in IFN-beta k.o. and wild type mice.
Laquinimod is a novel oral immunomodulatory substance, which is currently...
27th May, 2006
Active Biotech AB, Box 724, SE-220 07 Lund, Sweden. J Neuroimmunol. 2006 Apr;173(1-2):69-78. Epub 2006 Feb 10.
DOI Direct Link
In vitro metabolism and in vivo pharmacokinetics of quinoline 3-carboxamide derivatives in various species.
The metabolism of a group of quinoline 3-carboxamide derivatives was...
4th October, 2005
Preclinical Development, Active Biotech Research AB, SE-220 07 Lund, Xenobiotica. 2005 Mar;35(3):293-304.
DOI Direct Link
Cytochrome P450 3A4 is the major enzyme responsible for the metabolism of laquinimod, a novel immunomodulator.
In the present study, the involvement of cytochrome P450 enzyme(s) in the...
30th August, 2005
Preclinical Development, Active Biotech Research AB, Box 724, SE-220 07 Drug Metab Dispos. 2005 Jun;33(6):866-72. Epub 2005 Mar 11.
DOI Direct Link
Influence of IGF-IR stimulation or blockade on proliferation of human renal cell carcinoma cell lines.
Several tumors secrete insulin-like growth factors (IGFs) for autocrine...
3rd March, 2005
Active Biotech Research AB, Department of Cellular and Molecular Biology, Int J Oncol. 2004 Nov;25(5):1327-36.
Identification of protein-protein interfaces implicated in CD80-CD28 costimulatory signaling.
The B7 ligands CD80 and CD86 on APCs deliver either costimulatory or...
7th August, 2004
Active Biotech Research, Lund, Sweden. J Immunol. 2004 Jun 1;172(11):6803-9.
The histone deacetylase inhibitor Trichostatin A modulates CD4+ T cell responses.
BACKGROUND: Histone deacetylase inhibitors (HDACIs) induce...
28th May, 2004
Department of Biology, Active Biotech Research AB, P.O. Box 724, SE-22007 BMC Cancer. 2003 Nov 9;3:30.
DOI Direct Link
Synthesis and biological evaluation of new 1,2-dihydro-4-hydroxy-2-oxo-3-quinolinecarboxamides for treatment of autoimmune disorders: structure-activity relationship.
Roquinimex-related 3-quinolinecarboxamide derivatives were prepared and...
20th May, 2004
Active Biotech Research AB, Box 724, SE-220 07 Lund, Sweden. J Med Chem. 2004 Apr 8;47(8):2075-88.
DOI Direct Link
Interplay between superantigens and immunoreceptors.
Superantigens (SAGs) cause a massive T-cell proliferation by...
7th May, 2004
Active Biotech Research AB, Lund, Sweden. Scand J Immunol. 2004 Apr;59(4):345-55.
DOI Direct Link
A fast and parallel route to cyclic isothioureas and guanidines with use of microwave-assisted chemistry.
A fast and simple approach to novel cyclic isothioureas and related...
5th May, 2004
Department of Drug Discovery, Active Biotech AB, Box 724, 22007 Lund, J Org Chem. 2004 Mar 5;69(5):1571-80.
DOI Direct Link
Bcl-3 and NFkappaB p50-p50 homodimers act as transcriptional repressors in tolerant CD4+ T cells.
The transcriptional events that control T cell tolerance are still poorly...
5th May, 2004
Active Biotech Research Center, Scheelevagen 22, S-223 63 Lund, Sweden. J Biol Chem. 2004 Feb 27;279(9):8460-8. Epub 2003 Dec 10.
DOI Direct Link

«Active Biotech

This page contained an extended Active Biotech research listing. Click here to return to the Active Biotech main Biocorporate entry.

  Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.

All rights reserved. All other trademarks recognized.
Copyright 1997-2009 - BioPortfolio Limited.